15983557

Source:http://linkedlifedata.com/resource/pubmed/id/15983557

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002874, umls-concept:C0010592, umls-concept:C0018133, umls-concept:C0025677, umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0037047, umls-concept:C0376152, umls-concept:C1442162, umls-concept:C1514756, umls-concept:C1522577, umls-concept:C1527362, umls-concept:C1550718, umls-concept:C1708528
pubmed:issue	7
pubmed:dateCreated	2005-6-28
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA15704, http://linkedlifedata.com/resource/pubmed/grant/HL36444
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9600628
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1083-8791
pubmed:author	pubmed-author:DeegH JoachimHJ, pubmed-author:LeisenringWendyW, pubmed-author:MartinPaul JPJ, pubmed-author:SorrorMohamed LML, pubmed-author:StorbRainerR
pubmed:issnType	Print
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	567-8
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15983557-Anemia, Aplastic, pubmed-meshheading:15983557-Bone Marrow Transplantation, pubmed-meshheading:15983557-Cyclosporine, pubmed-meshheading:15983557-Female, pubmed-meshheading:15983557-Follow-Up Studies, pubmed-meshheading:15983557-Graft vs Host Disease, pubmed-meshheading:15983557-Humans, pubmed-meshheading:15983557-Immunosuppressive Agents, pubmed-meshheading:15983557-Male, pubmed-meshheading:15983557-Methotrexate
pubmed:year	2005
pubmed:articleTitle	Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
pubmed:publicationType	Letter, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, N.I.H., Extramural